A novel urinary biomarker predicts 1-year mortality after discharge from intensive care

Abstract Rationale The urinary proteome reflects molecular drivers of disease. Objectives To construct a urinary proteomic biomarker predicting 1-year post-ICU mortality. Methods In 1243 patients, the urinary proteome was measured on ICU admission, using capillary electrophoresis coupled with mass s...

Full description

Bibliographic Details
Main Authors: Esther Nkuipou-Kenfack, Agnieszka Latosinska, Wen-Yi Yang, Marie-Céline Fournier, Alice Blet, Blerim Mujaj, Lutgarde Thijs, Elodie Feliot, Etienne Gayat, Harald Mischak, Jan A. Staessen, Alexandre Mebazaa, Zhen-Yu Zhang, The French and European Outcome Registry in Intensive Care Unit Investigators
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Critical Care
Subjects:
Online Access:https://doi.org/10.1186/s13054-019-2686-0
_version_ 1818970876804071424
author Esther Nkuipou-Kenfack
Agnieszka Latosinska
Wen-Yi Yang
Marie-Céline Fournier
Alice Blet
Blerim Mujaj
Lutgarde Thijs
Elodie Feliot
Etienne Gayat
Harald Mischak
Jan A. Staessen
Alexandre Mebazaa
Zhen-Yu Zhang
The French and European Outcome Registry in Intensive Care Unit Investigators
author_facet Esther Nkuipou-Kenfack
Agnieszka Latosinska
Wen-Yi Yang
Marie-Céline Fournier
Alice Blet
Blerim Mujaj
Lutgarde Thijs
Elodie Feliot
Etienne Gayat
Harald Mischak
Jan A. Staessen
Alexandre Mebazaa
Zhen-Yu Zhang
The French and European Outcome Registry in Intensive Care Unit Investigators
author_sort Esther Nkuipou-Kenfack
collection DOAJ
description Abstract Rationale The urinary proteome reflects molecular drivers of disease. Objectives To construct a urinary proteomic biomarker predicting 1-year post-ICU mortality. Methods In 1243 patients, the urinary proteome was measured on ICU admission, using capillary electrophoresis coupled with mass spectrometry along with clinical variables, circulating biomarkers (BNP, hsTnT, active ADM, and NGAL), and urinary albumin. Methods included support vector modeling to construct the classifier, Cox regression, the integrated discrimination (IDI), and net reclassification (NRI) improvement, and area under the curve (AUC) to assess predictive accuracy, and Proteasix and protein-proteome interactome analyses. Measurements and main results In the discovery (deaths/survivors, 70/299) and test (175/699) datasets, the new classifier ACM128, mainly consisting of collagen fragments, yielding AUCs of 0.755 (95% CI, 0.708–0.798) and 0.688 (0.656–0.719), respectively. While accounting for study site and clinical risk factors, hazard ratios in 1243 patients were 2.41 (2.00–2.91) for ACM128 (+ 1 SD), 1.24 (1.16–1.32) for the Charlson Comorbidity Index (+ 1 point), and ≥ 1.19 (P ≤ 0.022) for other biomarkers (+ 1 SD). ACM128 improved (P ≤ 0.0001) IDI (≥ + 0.50), NRI (≥ + 53.7), and AUC (≥ + 0.037) over and beyond clinical risk indicators and other biomarkers. Interactome mapping, using parental proteins derived from sequenced peptides included in ACM128 and in silico predicted proteases, including/excluding urinary collagen fragments (63/35 peptides), revealed as top molecular pathways protein digestion and absorption, lysosomal activity, and apoptosis. Conclusions The urinary proteomic classifier ACM128 predicts the 1-year post-ICU mortality over and beyond clinical risk factors and other biomarkers and revealed molecular pathways potentially contributing to a fatal outcome.
first_indexed 2024-12-20T14:43:27Z
format Article
id doaj.art-75856f679f5c40cd8d8c09326b1f1831
institution Directory Open Access Journal
issn 1364-8535
language English
last_indexed 2024-12-20T14:43:27Z
publishDate 2020-01-01
publisher BMC
record_format Article
series Critical Care
spelling doaj.art-75856f679f5c40cd8d8c09326b1f18312022-12-21T19:37:11ZengBMCCritical Care1364-85352020-01-0124111110.1186/s13054-019-2686-0A novel urinary biomarker predicts 1-year mortality after discharge from intensive careEsther Nkuipou-Kenfack0Agnieszka Latosinska1Wen-Yi Yang2Marie-Céline Fournier3Alice Blet4Blerim Mujaj5Lutgarde Thijs6Elodie Feliot7Etienne Gayat8Harald Mischak9Jan A. Staessen10Alexandre Mebazaa11Zhen-Yu Zhang12The French and European Outcome Registry in Intensive Care Unit InvestigatorsMosaiques Diagnostics GmbHMosaiques Diagnostics GmbHStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of LeuvenDepartment of Anesthesiology and Intensive Care, Saint Louis-Lariboisière – Fernand Widal University Hospital, Assistance Publique Hôpitaux de ParisDepartment of Anesthesiology and Intensive Care, Saint Louis-Lariboisière – Fernand Widal University Hospital, Assistance Publique Hôpitaux de ParisStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of LeuvenStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of LeuvenDepartment of Anesthesiology and Intensive Care, Saint Louis-Lariboisière – Fernand Widal University Hospital, Assistance Publique Hôpitaux de ParisDepartment of Anesthesiology and Intensive Care, Saint Louis-Lariboisière – Fernand Widal University Hospital, Assistance Publique Hôpitaux de ParisMosaiques Diagnostics GmbHStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of LeuvenDepartment of Anesthesiology and Intensive Care, Saint Louis-Lariboisière – Fernand Widal University Hospital, Assistance Publique Hôpitaux de ParisStudies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of LeuvenAbstract Rationale The urinary proteome reflects molecular drivers of disease. Objectives To construct a urinary proteomic biomarker predicting 1-year post-ICU mortality. Methods In 1243 patients, the urinary proteome was measured on ICU admission, using capillary electrophoresis coupled with mass spectrometry along with clinical variables, circulating biomarkers (BNP, hsTnT, active ADM, and NGAL), and urinary albumin. Methods included support vector modeling to construct the classifier, Cox regression, the integrated discrimination (IDI), and net reclassification (NRI) improvement, and area under the curve (AUC) to assess predictive accuracy, and Proteasix and protein-proteome interactome analyses. Measurements and main results In the discovery (deaths/survivors, 70/299) and test (175/699) datasets, the new classifier ACM128, mainly consisting of collagen fragments, yielding AUCs of 0.755 (95% CI, 0.708–0.798) and 0.688 (0.656–0.719), respectively. While accounting for study site and clinical risk factors, hazard ratios in 1243 patients were 2.41 (2.00–2.91) for ACM128 (+ 1 SD), 1.24 (1.16–1.32) for the Charlson Comorbidity Index (+ 1 point), and ≥ 1.19 (P ≤ 0.022) for other biomarkers (+ 1 SD). ACM128 improved (P ≤ 0.0001) IDI (≥ + 0.50), NRI (≥ + 53.7), and AUC (≥ + 0.037) over and beyond clinical risk indicators and other biomarkers. Interactome mapping, using parental proteins derived from sequenced peptides included in ACM128 and in silico predicted proteases, including/excluding urinary collagen fragments (63/35 peptides), revealed as top molecular pathways protein digestion and absorption, lysosomal activity, and apoptosis. Conclusions The urinary proteomic classifier ACM128 predicts the 1-year post-ICU mortality over and beyond clinical risk factors and other biomarkers and revealed molecular pathways potentially contributing to a fatal outcome.https://doi.org/10.1186/s13054-019-2686-0BiomarkerIntensive care medicineHeart failureMortalityUrinary proteomics
spellingShingle Esther Nkuipou-Kenfack
Agnieszka Latosinska
Wen-Yi Yang
Marie-Céline Fournier
Alice Blet
Blerim Mujaj
Lutgarde Thijs
Elodie Feliot
Etienne Gayat
Harald Mischak
Jan A. Staessen
Alexandre Mebazaa
Zhen-Yu Zhang
The French and European Outcome Registry in Intensive Care Unit Investigators
A novel urinary biomarker predicts 1-year mortality after discharge from intensive care
Critical Care
Biomarker
Intensive care medicine
Heart failure
Mortality
Urinary proteomics
title A novel urinary biomarker predicts 1-year mortality after discharge from intensive care
title_full A novel urinary biomarker predicts 1-year mortality after discharge from intensive care
title_fullStr A novel urinary biomarker predicts 1-year mortality after discharge from intensive care
title_full_unstemmed A novel urinary biomarker predicts 1-year mortality after discharge from intensive care
title_short A novel urinary biomarker predicts 1-year mortality after discharge from intensive care
title_sort novel urinary biomarker predicts 1 year mortality after discharge from intensive care
topic Biomarker
Intensive care medicine
Heart failure
Mortality
Urinary proteomics
url https://doi.org/10.1186/s13054-019-2686-0
work_keys_str_mv AT esthernkuipoukenfack anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT agnieszkalatosinska anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT wenyiyang anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT mariecelinefournier anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT aliceblet anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT blerimmujaj anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT lutgardethijs anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT elodiefeliot anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT etiennegayat anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT haraldmischak anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT janastaessen anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT alexandremebazaa anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT zhenyuzhang anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT thefrenchandeuropeanoutcomeregistryinintensivecareunitinvestigators anovelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT esthernkuipoukenfack novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT agnieszkalatosinska novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT wenyiyang novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT mariecelinefournier novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT aliceblet novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT blerimmujaj novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT lutgardethijs novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT elodiefeliot novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT etiennegayat novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT haraldmischak novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT janastaessen novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT alexandremebazaa novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT zhenyuzhang novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare
AT thefrenchandeuropeanoutcomeregistryinintensivecareunitinvestigators novelurinarybiomarkerpredicts1yearmortalityafterdischargefromintensivecare